With a winning combination of outstanding research, a proven track record and talented analysts, we create a truly compelling proposition for investors. GeoInvesting’s investment solutions come from a place of innovation and a commitment to risk management.
By Maj Soueidan, Co-founder, GeoInvesting
I began my full-time investor career path while in college between 1988 to 1992. From time to time, I find myself struggling to shed some of the bad habits that get in the way of maximizing my investment experience. I think a lot of investors can sympathize with these problems, so I decided to make a top ten list of rules to follow for those that are thinking about becoming a full-time investor. Hopefully, this will help you learn from my experience. Read the entire article here…
More Educational Content – Check Back Often!
One of the unique things that sets GeoInvesting’s service apart from other research firms isn’t just the institutional quality of our research – but the fact that we provide it to our members as we work to undertake it. This means that our members get a “cradle to grave” view of our research methodology every [...]
Posted: April 9, 2019
One of the strongest performing biopharmaceutical stocks this year is Evolus (EOLS). When the FDA on February 1 approved the company’s lead product Jeuveau, a potential Botox competitor, the stock shot up to about $25 per share. Since then its shares have held stable, even touching $30 per share. SanaCurrents, which tracks market-moving catalysts of [...]
Posted: March 25, 2019
Hunting vs. Gathering By David Baker, Managing Principle, Mercadyne Funds When considering various individual investments (long or short) for your portfolio, one should go hunting, not gathering. Gathering is passively purchasing securities, fairly immediately, when one learns about them (from a friend, magazine article, online research report, brand affinity, etc.). Perhaps it even includes [...]
Posted: February 14, 2019
Director Joseph Manko of Horton Capital Management was an insider that we came to know as a recurring Form 4 filer for Repro-Med. His filings helped shape the way we viewed Repro Med Systems (OOTC:REPR) as an investment, especially through the tumult that the company had to endure over a several-year period. We've covered REPR [...]
Posted: January 23, 2019
On October 17, 2018, Form 4 insider transactions by the CEO of Ever-Glory International Group, (NASDAQ:EVK), where he made a direct purchase of 174,800 shares, prompted us to add the stock to our model swing trade portfolio at $3.25.We made this available to premium members and 7-day free trial subscribers.While the core focus of our [...]
Posted: December 27, 2018
Viewing page 1 of 3|Next Page